VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
35 hedge funds and large institutions have $15.7M invested in Vincerx Pharma, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$176K | |
| 2 | +$47.6K | |
| 3 | +$45.1K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.58K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.12K |
Top Sellers
| 1 | -$411K | |
| 2 | -$325K | |
| 3 | -$106K | |
| 4 |
TC
Tejara Capital
London,
United Kingdom
|
-$74.8K |
| 5 |
BlackRock
New York
|
-$63.6K |